These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 18608912)

  • 81. Isolation and purification of antigenic components of Cryptococcus.
    Wozniak KL; Levitz SM
    Methods Mol Biol; 2009; 470():71-83. PubMed ID: 19089377
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Glucuronoxylomannan intranasal challenge prior to Cryptococcus neoformans pulmonary infection enhances cerebral cryptococcosis in rodents.
    Lee HH; Carmichael DJ; Ríbeiro V; Parisi DN; Munzen ME; Charles-Niño CL; Hamed MF; Kaur E; Mishra A; Patel J; Rooklin RB; Sher A; Carrillo-Sepulveda MA; Eugenin EA; Dores MR; Martinez LR
    PLoS Pathog; 2023 Apr; 19(4):e1010941. PubMed ID: 37115795
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Monoclonal antibodies to Cryptococcus neoformans glucuronoxylomannan enhance fluconazole efficacy.
    Mukherjee J; Feldmesser M; Scharff MD; Casadevall A
    Antimicrob Agents Chemother; 1995 Jul; 39(7):1398-405. PubMed ID: 7492075
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Genetic control of the humoral response to cryptococcal capsular polysaccharide in mice.
    Dromer F; Yeni P; Charreire J
    Immunogenetics; 1988; 28(6):417-24. PubMed ID: 2460403
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Mechanism for the isotype dependence of antibody-mediated toxicity in Cryptococcus neoformans-infected mice.
    Lendvai N; Qu XW; Hsueh W; Casadevall A
    J Immunol; 2000 Apr; 164(8):4367-74. PubMed ID: 10754337
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Association Between Plasma Antibody Responses and Risk for Cryptococcus-Associated Immune Reconstitution Inflammatory Syndrome.
    Yoon HA; Nakouzi A; Chang CC; Kuniholm MH; Carreño LJ; Wang T; Ndung'u T; Lewin SR; French MA; Pirofski LA
    J Infect Dis; 2019 Jan; 219(3):420-428. PubMed ID: 30010905
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Pathogenesis of pulmonary Cryptococcus neoformans infection in the rat.
    Goldman D; Lee SC; Casadevall A
    Infect Immun; 1994 Nov; 62(11):4755-61. PubMed ID: 7927751
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Identification of Disease-Associated Cryptococcal Proteins Reactive With Serum IgG From Cryptococcal Meningitis Patients.
    Gressler AE; Volke D; Firacative C; Schnabel CL; Müller U; Krizsan A; Schulze-Richter B; Brock M; Brombacher F; Escandón P; Hoffmann R; Alber G
    Front Immunol; 2021; 12():709695. PubMed ID: 34367172
    [No Abstract]   [Full Text] [Related]  

  • 89. Cryptococcal disease in patients with or without human immunodeficiency virus: clinical presentation and monitoring of serum cryptococcal antigen titers.
    Lin TY; Yeh KM; Lin JC; Wang NC; Peng MY; Chang FY
    J Microbiol Immunol Infect; 2009 Jun; 42(3):220-6. PubMed ID: 19812855
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Capsular localization of the Cryptococcus neoformans polysaccharide component galactoxylomannan.
    De Jesus M; Nicola AM; Rodrigues ML; Janbon G; Casadevall A
    Eukaryot Cell; 2009 Jan; 8(1):96-103. PubMed ID: 18952901
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Analysis of asthma patients for cryptococcal seroreactivity in an urban German area.
    Grahnert A; Müller U; von Buttlar H; Treudler R; Alber G
    Med Mycol; 2015 Aug; 53(6):576-86. PubMed ID: 26026172
    [TBL] [Abstract][Full Text] [Related]  

  • 92. In vitro and in vivo stability of a Cryptococcus neoformans [corrected] glucuronoxylomannan epitope that elicits protective antibodies.
    Cleare W; Cherniak R; Casadevall A
    Infect Immun; 1999 Jun; 67(6):3096-107. PubMed ID: 10338526
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Antibodies to keyhole limpet hemocyanin cross-react with an epitope on the polysaccharide capsule of Cryptococcus neoformans and other carbohydrates: implications for vaccine development.
    May RJ; Beenhouwer DO; Scharff MD
    J Immunol; 2003 Nov; 171(9):4905-12. PubMed ID: 14568972
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Dectin-3 Recognizes Glucuronoxylomannan of
    Huang HR; Li F; Han H; Xu X; Li N; Wang S; Xu JF; Jia XM
    Front Immunol; 2018; 9():1781. PubMed ID: 30131805
    [No Abstract]   [Full Text] [Related]  

  • 95. Intravascular cryptococcal culture filtrate (CneF) and its major component, glucuronoxylomannan, are potent inhibitors of leukocyte accumulation.
    Dong ZM; Murphy JW
    Infect Immun; 1995 Mar; 63(3):770-8. PubMed ID: 7868246
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Improved survival of mice deficient in secretory immunoglobulin M following systemic infection with Cryptococcus neoformans.
    Subramaniam KS; Datta K; Marks MS; Pirofski LA
    Infect Immun; 2010 Jan; 78(1):441-52. PubMed ID: 19901068
    [TBL] [Abstract][Full Text] [Related]  

  • 97. A human IgM monoclonal antibody prolongs survival of mice with lethal cryptococcosis.
    Fleuridor R; Zhong Z; Pirofski L
    J Infect Dis; 1998 Oct; 178(4):1213-6. PubMed ID: 9806064
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Evidence for interference by immune complexes in the serodiagnosis of cryptococcosis.
    Sadamoto S; Ikeda R; Nishikawa A; Shinoda T
    Microbiol Immunol; 1993; 37(2):129-33. PubMed ID: 8502177
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Human immunoglobulin G2 (IgG2) and IgG4, but not IgG1 or IgG3, protect mice against Cryptococcus neoformans infection.
    Beenhouwer DO; Yoo EM; Lai CW; Rocha MA; Morrison SL
    Infect Immun; 2007 Mar; 75(3):1424-35. PubMed ID: 17220317
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Binding and internalization of glucuronoxylomannan, the major capsular polysaccharide of Cryptococcus neoformans, by murine peritoneal macrophages.
    Chang ZL; Netski D; Thorkildson P; Kozel TR
    Infect Immun; 2006 Jan; 74(1):144-51. PubMed ID: 16368967
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.